These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25997964)

  • 1. A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel.
    Lv S; Ye M; Wang X; Li Z; Chen X; Dou X; Dai Y; Zeng F; Luo L; Wang C; Li K; Luo X; Yan J; Li X
    Neoplasma; 2015; 62(4):531-40. PubMed ID: 25997964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
    Chen X; Lv H; Ye M; Wang S; Ni E; Zeng F; Cao C; Luo F; Yan J
    Int J Pharm; 2012 Apr; 426(1-2):248-255. PubMed ID: 22310463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner.
    Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ
    Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and characterization of fusion protein tTF/SA as a universal effector for targeting blood coagulation].
    Wang Z; Yan JH; Wang JP; Xie LY; Wu N
    Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):218-22. PubMed ID: 17460891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-factor fusion proteins induce occlusion of tumor vessels.
    Schwöppe C; Kessler T; Persigehl T; Liersch R; Hintelmann H; Dreischalück J; Ring J; Bremer C; Heindel W; Mesters RM; Berdel WE
    Thromb Res; 2010 Apr; 125 Suppl 2():S143-50. PubMed ID: 20433995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.
    Hu P; Yan J; Sharifi J; Bai T; Khawli LA; Epstein AL
    Cancer Res; 2003 Aug; 63(16):5046-53. PubMed ID: 12941833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arginine-glycine-aspartic polypeptide mediated truncated tissue factor therapy for colorectal carcinoma].
    Huang ZJ; Luo Q; Yan JH; Wang SY
    Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(8):619-24. PubMed ID: 20646482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Humanized monoclonal antibody TNT-3-mediated truncated tissue factor for the treatment of H22 hepatoma-bearing mice].
    Huang ZJ; Wang R; Liu ZZ; Wang SY; Yan JH; Luo Q
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):249-53. PubMed ID: 22781034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene expression and activities analysis of a new fusion protein (RGD) 3/tTF].
    Yan JH; Yang GW; Wang JP; Wu N; Zhuang GH
    Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):409-12. PubMed ID: 17577984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of fusion proteins for selective occlusion of tumor vessels.
    Kessler T; Schwöppe C; Liersch R; Schliemann C; Hintelmann H; Bieker R; Berdel WE; Mesters RM
    Curr Drug Discov Technol; 2008 Mar; 5(1):1-8. PubMed ID: 18537561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
    Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
    Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
    Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
    Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction.
    Shi Q; Zhang Y; Liu S; Liu G; Xu J; Zhao X; Anderson GJ; Nie G; Li S
    Biochem Pharmacol; 2018 Oct; 156():501-510. PubMed ID: 30222966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the vasculature of colorectal carcinoma with a fused protein of (RGD)₃-tTF.
    Huang ZJ; Zhao Y; Luo WY; You J; Li SW; Yi WC; Wang SY; Yan JH; Luo Q
    ScientificWorldJournal; 2013; 2013():637086. PubMed ID: 23861656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging.
    Persigehl T; Ring J; Bremer C; Heindel W; Holtmeier R; Stypmann J; Claesener M; Hermann S; Schäfers M; Zerbst C; Schliemann C; Mesters RM; Berdel WE; Schwöppe C
    Angiogenesis; 2014 Jan; 17(1):235-46. PubMed ID: 24136410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
    Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Li T; Liu C; Wang L; Wang L; Luo F; Wu T; Yan J
    Int J Oncol; 2019 Oct; 55(4):823-832. PubMed ID: 31432158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
    Bieker R; Kessler T; Schwöppe C; Padró T; Persigehl T; Bremer C; Dreischalück J; Kolkmeyer A; Heindel W; Mesters RM; Berdel WE
    Blood; 2009 May; 113(20):5019-27. PubMed ID: 19179306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.
    Brand C; Dencks S; Schmitz G; Mühlmeister M; Stypmann J; Ross R; Hintelmann H; Schliemann C; Müller-Tidow C; Mesters RM; Berdel WE; Schwöppe C
    J Ultrasound Med; 2015 Jul; 34(7):1227-36. PubMed ID: 26112625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.